Clinical trial
SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus…
NCT00307047 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00307047 |
|---|---|
| Title | SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System |
| Official title | SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | XIENCE V® Everolimus Eluting Coronary Stent, TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent |
| Enrollment | 3,687 |
| Start date | Aug 1, 2006 |
| Primary completion | Aug 1, 2009 |
| Completion | May 1, 2012 |
| First posted | Mar 27, 2006 |
| Last update posted | Nov 7, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: